chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a nurse referring to a 17 year old patient of unknown gender. The patient's concurrent conditions, medical history or concomitant medications were not reported. On 30-MAY-2017, the patient was vaccinated with the first and expired dose of GARDASIL, with lot # K007264 and an expiration date on 02-MAR-2017 (strength and dose were not reported) for prophylaxis. No adverse effects were reported. Additional information has been requested
(rash with) Blisters; Rash from head to toe/Rash covered whole body; This spontaneous case was reported by a pharmacist and describes the occurrence of BLISTER ((rash with) Blisters) and RASH (Rash from head to toe/Rash covered whole body) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced BLISTER ((rash with) Blisters) and RASH (Rash from head to toe/Rash covered whole body). At the time of the report, BLISTER ((rash with) Blisters) and RASH (Rash from head to toe/Rash covered whole body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitants were provided. No treatment medications were reported.
Fever, Runny Nose/Congestion, Sore Throat, Cough  recent diagnosis of lung cancer on the left side.  He had a left lung biopsy yesterday.  Last night he developed shortness of breath.  He is very dyspneic.  He normally is on oxygen from 2-4 L. On 4 L he was in the mid 70s on EMS arrival.  They placed him on oxygen but his oxygen status was still low and he was tachypneic.  He was placed on CPAP with improvement.  He also received steroid, Solu-Medrol as well as breathing treatments.  No chest pain.  No abdominal pain.  No nausea vomiting.  No fever.  patient reports having his 2nd dose of COVID vaccine 2 weeks ago  In ER, patient was noted to be in AFib with RVR.  The per patient and wife was at bedside, he does not have any history of atrial fibrillation. Death on 3/31/2021
March 9th - Took vaccine April 1st - started feeling tingling sensations and numbness in both arms, and sometimes the legs April 15th - a white plaque under tongue  April 23rd - went to a doctor's office in Mexico to get blood test and a CAT scan of the brain to check neuro activity due to tingling sensations (they said nothing was found) July 7th - tested positive for COVID  July 15th - tingling sensation and numbness started again, even worse August 25th - flew to see the best neurologist in town  August 29th - discovered I was suffering from a viral inflammation that attacked my nervous system, caused by vaccines (ADEM) September 1st - started my treatment with corticosteroids for 5 consecutive days by IV injections September 5th - last day of treatment  October 1st - no signs of betterment, started another treatment with corticosteroids
Herpes Zoster; Information was received from a lawyer regarding a case in litigation involving a female patient of unknown age.  On an unknown date, the patient was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).  Shortly after receiving the vaccine the patient suffered a painful outbreak of open sore rashes on both legs from her groin to her feet which then progressed to her back.  She presented to her medical provider who diagnosed her with herpes zoster. Despite receiving treatment she continued to suffer from herpes zoster.  As a direct and proximate result of receiving zoster vaccine live (ZOSTAVAX) the patients symptoms have resulted in physical limitations not present prior to using the product.  She also experienced mental and emotional distress due to resulting physical limitations and seriousness of condition.  As a result of zoster vaccine live (ZOSTAVAX) the patient suffered severe and permanent personal injuries.    Herpes zoster was considered to be disabling.    Additional information has been requested.
I had hives appear over much of my body starting about 2 weeks after getting Moderna booster. My brother, sister, and friend all had the same happen. Itchiness and bumbs pretty bad for about 6 weeks, just going away now about 12 weeks later.  We all managed our symptoms with OTC antihistamines and hydrocortisone cream.
she developed blood clots in her lungs, legs and all over her body; she developed blood clots in her lungs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 75-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "She is allergic to a lot of things" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: Unknown), for COVID-19 immunization, reaction(s): "Clot blood"; Bnt162b2 (DOSE 2, SINGLE, Lot number: Unknown), for COVID-19 immunization, reaction(s): "She got clot in lungs", "Clot blood". The following information was reported: THROMBOSIS (medically significant), outcome "unknown", described as "she developed blood clots in her lungs, legs and all over her body"; PULMONARY THROMBOSIS (medically significant), outcome "unknown", described as "she developed blood clots in her lungs".  Clinical course: Reporter States she wants to know the ingredients as after she took the pfizer covid vaccine, she developed blood clots in her lungs, legs and all over her body. States she almost died. States she has respiratory problems (unclear of timing) and needs to take the 'lung vaccine."  States she is allergic to a lot of things. She is not sure that she wants to take the Pfizer RSV vaccine as states pfizer has ingredients in their vaccine (covid) that 'is not good for her."   Upon further clarification, caller states she had 2 Pfizer covid shots and one pfizer booster for covid and after every shot, she developed blood clots. Also states last year, she had a flu vaccine that was 'mixed' together with a pfizer covid vaccine and developed blood clots as well. Attempted to clarify further however caller unable to clarify. states she is 75 years of age.    The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300311939 same reporter, patient, event, different dose;US-PFIZER INC-202300312116 same reporter, patient, event, different dose;
arm got a little bit sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm got a little bit sore) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disorder (The patient was on unspecified heart medication.).    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (arm got a little bit sore). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site pain, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (arm got a little bit sore) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.
she's had to take an inhaler after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (she's had to take an inhaler after the first dose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION COMPLICATION (she's had to take an inhaler after the first dose). The patient was treated with ALBUTEROL [SALBUTAMOL] for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (she's had to take an inhaler after the first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.   This case was linked to MOD-2021-362537 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Oct-2021: Follow up received and fax number of Reporter was  updated.
nausea, stomach ache, headache, cold (feeling of being cold), numb toes, stiff neck, aching joints-  sharp painful elbows, knees, neck, shoulders, hips.
Initial report received from a healthcare professional on 20 September 2013. A female patient, whose date of birth, age at the time of events, medical history, illness at the time of vaccination and concomitant medication were not reported, had received a dose of Influenza vaccine (lot number: not reported, dose number, route and anatomical site of administration were not reported) on an unspecified date of October 2012. On an unspecified date of October 2012 after vaccination, the patient had rising TSH levels. The patient was seen endocrinologist physician. Laboratory investigations and corrective medications were not reported. At the time of this report, the patient had not recovered from events. Documents held by sender: None.
pt recv vax 14JUN95 & 22JAN96 pt exp chickenpox & fever;f/u info recv from MD indicated that the pt recovered;
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 22-OCT-2015, the patient was vaccinated with improperly stored GARDASIL 9 (strength, dose and route of administration were not reported, lot # L007560, expiration date: 15-JUN-2017). No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
seizure; This is a spontaneous report from a non-contactable consumer via the Pfizer-sponsored program. A female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. As reported, caller was calling regarding his daughter who got the 1st dose and then after the 1st dose she had a seizure. She had about 3500.00 in expenses and wanted to talk to someone about it. The daughter had a seizure 14 minutes after taking 1st dose of the Covid vaccine. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This was booster dose and got the same injection site pain and chills experienced with first dose. However, after three days this booster dose resulted in red blotches on my arm about two inches below injection site. Blotches we raised but not painful.
I am a front line  physician and got my first dose of Pfizer vaccine on 12/21/2020.  For the first two days after the shot, I had only injection site soreness and mild headache, but nothing serious (Grade 1 effects). was able to go to work with that easily.  On the tenth day (December 31, 2020) after dose 1 of  Pfizer vaccine, I started to get severe myalgias, headache, chills, neck and back pain, mental fogging, malaise, altered taste, and fever spiking up to 101.2. I took Tylenol and tried to sleep. Woke up at 2 am with worst chills of my life, not improved my several blankets.  My initial thought was that I have gotten COVID 19 before vaccine could take effect.  I got 3  negative PCR tests done at hospital, first one on  1/2/2021  (day 3 of symptoms and day 13 after vaccine),  second one on  1/5/2021 (Day 6 of symptoms and day 16 after vaccine), and third one on 1/8/2021 (Day 9 after symptoms and day 19 after vaccine).  My  symptoms are still persisting  (today is Day 12 of  symptoms and Day 22 after vaccine), but have slightly improved in last few days. I have not been able to do any activities of daily life (Grade 3). Have been taking Tylenol 3 times a day,  bed rest, hydration.  I have been the biggest supporter of the vaccines, but now totally unsure. I have talked to several ID and Immunology colleagues and nobody can explain it. I reviewed Pfizer EUA document, and on page 41, a subset of people have been described who had COVID type symptoms but negative tests. May be I have a n atypical delayed and prolonged systemic reaction to dose 1.  I have decided not to take the Dose 2 and wait for a more traditional vaccine like Jonson and Johnson.
sneezing; running nose; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (sneezing) and RHINORRHOEA (running nose) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 16907577455) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced SNEEZING (sneezing) and RHINORRHOEA (running nose). At the time of the report, SNEEZING (sneezing) and RHINORRHOEA (running nose) outcome was unknown.            No concomitant medications were provided. No Treatment Information was provided.
Injection site pain, tenderness, pain under right armpit, fatigue, headache, muscle pain, joint pain and chills.
Patient received Bivalent booster 9/14/22.  10/3/22 she called the office to report that since she received Bivalent vaccine she has had neck, shoulder, right arm pain down to elbow since then. Symptoms started shortly after receiving vaccine. No other signs or symptoms besides pain. She received J&J vaccine 3/11/21.
Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had been administered dose of GARDASIL on 12-AUG-2013 (lot # H011350, Expiration Date: 21-FEB-2015). No adverse event was reported. This is one of the reports from the same source Additional information is not expected.
pt recv vax & devel severe SOB;pt hosp;MD comment on reporting form states CHF devel p/inj;
Listed on separate page. These events started soon after oral Typhoid was taken. 6-9-12 at 6:00 am. 1st dose taken. No symptoms. 6-11-12 at 6:00 am 2nd dose taken. 6:00 pm. 6-11-12 nausea began. On 6-12-12 6:00 am nausea, vomiting x one, abdominal cramps and diarrhea - lasting 2 - 3 hours. 3rd dose taken 6:00 am. 6-13-12. Diarrhea x one 3 1/2 hrs. later. Nausea continued throughout. 6-14-12 nausea, abdominal pain throughout the day and no appetite. 4th dose taken 6-15-12 at 6:00 am. nausea and abdominal cramps continued for 6 hours after final dose and diarrhea x one. 24 hours after final dose, symptoms resolved.
Severe myocarditis, left anterior fascicular block.  No positive outcomes.  Severe myocarditis lasted for one week and then scar tissue developed causing a left anterior fascicular block and delayed conduction through the ventricles.
Shingles (terrible case/ hospitalized)/ Shingles on the right lower side of my abdomen/back; Pain (worst pain); Blisters; Had Shingrex vaccine, got shingles/Suspected vaccination failure; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included COVID-19 VACCINE (COVID-19 BOOSTER) for prophylaxis.   On an unknown date, the patient received Shingrix and COVID-19 BOOSTER. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles (serious criteria hospitalization), pain (serious criteria hospitalization) and blister. The patient was treated with gabapentin. On an unknown date, the outcome of the vaccination failure, shingles, pain and blister were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, pain and blister to be related to Shingrix.     Additional Information: GSK receipt date: 01-Oct-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had the Shingrix vaccine and three weeks after his/her Covid booster, got a terrible case of shingles on the right lower side of my abdomen/back.  Outbreak was slow to appear on his/her skin so was hospitalized overnight trying to find the source of the pain. Blisters finally appeared after a week, then started Gabapentin mega doses for several months.  The patient had  worst pain, he/she ever endured. The patient still wonder whether the booster diminished the effectiveness of Shingrix vaccine. Additional supportive information: It was unknown if the reporter considered the shingles, pain and blister to be related to COVID-19 Booster. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
The patient briefly fainted about 7 minutes after getting the vaccine. EMS were called into the scene and the patient was fine.
Pt has tennis ball size swelling under her left armpit. It is causing her pain in her joints. Pt has taken Ibu and is going to the urgent care when they open.
Patient had gotten 2 doses of Pfizer COVID-19 shots in February, patient came up for a walk in appointment. Patient answered all screening questions before administration and declined any previous COVID-19 vaccinations.  After administration of the shot, patient remembered she had gotten 2 previous doses of the COVID-19 shot and showed her COVID-19 vaccination card.
This spontaneous report was received from a nurse refers to multiple patients of unknown age and gender. No pertinent medical history was reported. On an unknown date, multiple patients were vaccinated with RECOMBIVAX HB (lot # J009051 and expiration date 26-MAR-2016) dose 0.5 ml, subcutaneous injection post supported temperature excursion. No adverse effects were reported. No Product Quality Complaint (PQC) was involved. This is one of the several reports from the same source. Additional information has been requested.
Patient said she developed local erythema/swelling/itching to injection site and that it spread to her chest and abdomen. She developed a "bronchial cough" about 48 hours after receiving vaccine. She wanted antibiotics for cough from her primary care because her husband is having surgery on 3/15/21 and wanted to make sure she could go into the hospital with him. Her primary care provider prescribed her Ceftin 500 mg. She has taken Ceftin before without any allergic reaction. She said as soon as she started taking the Ceftin her entire body became itchy "down to her fingers" and had hives from head to toe. Also reports mild shortness of breath. Her provider was unsure whether the reaction was from the Ceftin with the vaccine or the Ceftin itself. Patient said her primary care may do some testing to find out if she is allergic to Ceftin.
It did swell a bit; It is itchy; Rash or small welts around the area I received my booster vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (It did swell a bit), VACCINATION SITE PRURITUS (It is itchy) and VACCINATION SITE RASH (Rash or small welts around the area I received my booster vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (It did swell a bit), VACCINATION SITE PRURITUS (It is itchy) and VACCINATION SITE RASH (Rash or small welts around the area I received my booster vaccine). At the time of the report, VACCINATION SITE SWELLING (It did swell a bit), VACCINATION SITE PRURITUS (It is itchy) and VACCINATION SITE RASH (Rash or small welts around the area I received my booster vaccine) outcome was unknown.            No concomitants were reported. No treatment is reported.
This spontaneous report as received from a registered nurse refers to an unspecified patients of unknown age and gender. No pertinent medical history, drug reactions/allergies and concomitant medications were reported. On an unspecified dates between September 2016 to October 2016, the unspecified patients were vaccinated with improperly stored doses of VARIVAX (lot # M009768 and expiry date 23-JAN-2018) (lot # M025866 and expiry date 24-MAY-2018) (dosing regimen unknown). On an unspecified dates between September 2016 to October 2016, VARIVAX with lot number M009768 was exposed to temperature excursion of 6.7 Fahrenheit for 2 hours and 3 minutes, 18.7F for 3 hours and 39 minutes, 11.9 F for 2 hours and 37 minutes, 10.3F for 1 hour and 22 minutes, 9.5F for 3 hours and 32 minutes, 9.4F for 2 hours and 53 minutes, 8.8F for 56 minutes, 9.7F for 4 hours and 42 minutes and with lot number M025866 was exposed to 9.4F for 2 hours and 53 minutes, 8.8F for 56 minutes and 9.7F for 4 hours and 42 minutes. No Previous temperature excursion were reported. The call was due to a digital date logger. No symptoms were reported. No product quality complaint was filed. Additional information has been requested.
I had an NSTEMI 1 week after having the omicron vaccine. They don't know what triggered it. I do....the darn vaccine!  1 week after the shot, out of nowhere I got up from my desk to go to the bathroom and had severe chest pain, couldn't breathe, and started to sweat profusely. My husband called the rescue and I was taken and admitted to the Hospital. I was told that I had a heart attack....an NSTEMI and they did not know the cause.
Fast heart rate; This is a spontaneous report from a contactable consumer (Patient). A female patient of an unspecified age received BNT162B2 (BNT162B2, solution for injection), dose 1 via an unspecified route of administration on 11May2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications was not reported. The patient had vaccine and experienced fast heart rate on 11May2021, and wanted to know if her reaction had anything to do with the vaccine. Outcome of the event was unknown.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.